Industries
Hospitals, pharmaceutical plants and medical-device manufacturing — Lupin, Syngenta (Goa), Jaslok, Jupiter and SevenHills hospitals.
Sector overview
Pharmaceutical assignments include the valuation and asset identification of Lupin, valuations for Neon Laboratories and Medilux Laboratories for State Bank of India, Pan Drugs, Sudarshan Pharma, Parental Drugs, Aastrid Life Sciences and Medizest, and TEV studies for Seya Industries, Nightingale Pharmaceuticals, Aneta Pharmaceuticals and Pacific Organics. Enterprise valuation has been delivered for Parental Drugs India for State Bank of India.
On the healthcare side the firm acted as Lenders’ Independent Engineer for SevenHills Healthcare in Mumbai (₹950 crore, for Allahabad Bank, Union Bank of India and UCO Bank) and for the 250-bed Royal Mudhol Hospital in Pune for State Bank of India, prepared the TEV study for a 300-bed hospital in Pune and for Ushahkal Abhinav and Nimai hospitals, and has valued Jaslok, Jupiter and SevenHills hospitals in Mumbai.
Industry challenges
A plant that cannot pass a regulatory inspection cannot ship. We review the approval pathway, good-manufacturing-practice status and the time and cost to clear observations before accepting the revenue schedule.
Hospital revenue depends on bed occupancy, case mix and the share of insured, corporate and government-scheme patients. We build the case on comparable facilities in the catchment, not on capacity.
Diagnostic and therapeutic equipment loses value quickly and is often vendor-financed. We value it on condition, vintage and service-contract status, and separate it from building and utilities.
New hospitals and formulation plants take longer to fill and qualify than promoters plan. We phase the ramp-up on evidence from comparable openings and test debt service on the slower path.
Our solutions
Viability of new hospitals, expansions and pharmaceutical plants, with regulatory, market and ramp-up review.
Learn moreConstruction monitoring and equipment-installation certification for lenders, from civil works through commissioning of medical and process equipment.
Learn moreValuation of formulation and API plants, hospital buildings and medical equipment for security, restructuring and resolution.
Learn moreTrack record
| Client | Location | Service | Value |
|---|---|---|---|
| SevenHills Healthcare (for Allahabad Bank, Union Bank of India and UCO Bank) | Mumbai | Lenders’ Independent Engineer | ₹950 Cr |
| Royal Mudhol Hospital, 250 beds (for State Bank of India) | Pune | Lenders’ Engineer | ₹190 Cr |
| Lupin | Multiple plants | Valuation and asset identification | |
| Neon Laboratories (for State Bank of India) | Valuation | ||
| Parental Drugs India (for State Bank of India) | Enterprise valuation | ||
| Jaslok Hospital, Jupiter Hospital and SevenHills Hospital | Mumbai | Valuation | |
| Seya Industries | TEV study | ||
| 300-bed hospital | Pune | TEV study |
Case study
Renewable Energy
Techno-Economic Viability study across two locations covering 152 MW wind, 500 MW solar and 600 MW of battery energy storage.
TEV StudyInfrastructure
Project Monitoring Agency across ten concurrent national mandates including the Nagpur–Mumbai Expressway, Delhi–Meerut RRTS, the Rohtang Pass tunnel and the Mumbai–Pune Missing Link.
Project MonitoringConstruction
Project Monitoring Agency across ten construction projects including CIDCO Navi Mumbai, MHADA and the Karwar Naval Base.
Project Monitoring
